APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isothermal Nucleic Acid Amplification

Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get the statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish the reaction.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get the statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish the reaction.

Selected research

Market Outlook & Growth Opportunities

Global Isothermal Nucleic Acid Amplification Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchIsothermal Nucleic Acid Amplification Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Isothermal Nucleic Acid Amplification Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Isothermal Nucleic Acid Amplification Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isothermal Nucleic Acid Amplification Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Isothermal Nucleic Acid Amplification Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get the statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish the reaction.

Currently, some companies in the world can produce isothermal nucleic acid amplification product, mainly concentrating in North America and Europe. The main market players are PreAnalytiX, Meridian Bioscience, Eiken Chemical, Lucigen, OptiGene, etc.

This report provides an overview of the global Isothermal Nucleic Acid Amplification market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Isothermal Nucleic Acid Amplification and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isothermal Nucleic Acid Amplification sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isothermal Nucleic Acid Amplification market size, projected growth trends, production technologies, key applications, and end-use industries.

Isothermal Nucleic Acid Amplification Segment by Company

PreAnalytiX

Meridian Bioscience

Eiken Chemical

Lucigen

OptiGene

NEB

Biomerieux

Abbott

Quidel Corporation

Promega

Hologic

Ustar

Grifols

ThermoFisher

Nugen

Isothermal Nucleic Acid Amplification Segment by Type

LAMP

HDA

Other

Isothermal Nucleic Acid Amplification Segment by Application

Research Use

Foods Inspection

Environment Inspection

Isothermal Nucleic Acid Amplification Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isothermal Nucleic Acid Amplification status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Isothermal Nucleic Acid Amplification market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isothermal Nucleic Acid Amplification significant trends, drivers, influence factors in global and regions.

6. To analyze Isothermal Nucleic Acid Amplification competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isothermal Nucleic Acid Amplification market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isothermal Nucleic Acid Amplification and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isothermal Nucleic Acid Amplification.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isothermal Nucleic Acid Amplification market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isothermal Nucleic Acid Amplification industry.

Chapter 3: Detailed analysis of Isothermal Nucleic Acid Amplification manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Isothermal Nucleic Acid Amplification in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Isothermal Nucleic Acid Amplification in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isothermal Nucleic Acid Amplification Industry Trends Table 2. Isothermal Nucleic Acid Amplification Industry Drivers Table 3. Isothermal Nucleic Acid Amplification Industry Opportunities and Challenges Table 4. Isothermal Nucleic Acid Amplification Industry Restraints Table 5. Global Isothermal Nucleic Acid Amplification Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isothermal Nucleic Acid Amplification Revenue Share by Company (2021-2026) Table 7. Global Isothermal Nucleic Acid Amplification Sales Volume by Company (units) & (2021-2026) Table 8. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Company (2021-2026) Table 9. Global Isothermal Nucleic Acid Amplification Average Price (USD/unit) of Company (2021-2026) Table 10. Global Isothermal Nucleic Acid Amplification Company Ranking, (2024-2026) & (USD Million) Table 11. Global Isothermal Nucleic Acid Amplification Key Company Manufacturing Base & Headquarters Table 12. Global Isothermal Nucleic Acid Amplification Company, Product Type & Application Table 13. Global Isothermal Nucleic Acid Amplification Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Isothermal Nucleic Acid Amplification by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of LAMP Table 18. Significant Companies of HDA Table 19. Significant Companies of Other Table 20. Global Isothermal Nucleic Acid Amplification Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Isothermal Nucleic Acid Amplification Sales Volume by Type (2021-2026) & (units) Table 22. Global Isothermal Nucleic Acid Amplification Sales Volume by Type (2027-2032) & (units) Table 23. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Type (2021-2026) Table 24. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Type (2027-2032) Table 25. Global Isothermal Nucleic Acid Amplification Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Isothermal Nucleic Acid Amplification Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Isothermal Nucleic Acid Amplification Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Isothermal Nucleic Acid Amplification Sales Value Share by Type (2021-2026) Table 29. Global Isothermal Nucleic Acid Amplification Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Research Use Table 31. Significant Companies of Foods Inspection Table 32. Significant Companies of Environment Inspection Table 33. Global Isothermal Nucleic Acid Amplification Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 34. Global Isothermal Nucleic Acid Amplification Sales Volume by Application (2021-2026) & (units) Table 35. Global Isothermal Nucleic Acid Amplification Sales Volume by Application (2027-2032) & (units) Table 36. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Application (2021-2026) Table 37. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Application (2027-2032) Table 38. Global Isothermal Nucleic Acid Amplification Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Isothermal Nucleic Acid Amplification Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Isothermal Nucleic Acid Amplification Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Isothermal Nucleic Acid Amplification Sales Value Share by Application (2021-2026) Table 42. Global Isothermal Nucleic Acid Amplification Sales Value Share by Application (2027-2032) Table 43. Global Isothermal Nucleic Acid Amplification Sales by Region: 2021 VS 2025 VS 2032 (units) Table 44. Global Isothermal Nucleic Acid Amplification Sales by Region (2021-2026) & (units) Table 45. Global Isothermal Nucleic Acid Amplification Sales Market Share by Region (2021-2026) Table 46. Global Isothermal Nucleic Acid Amplification Sales by Region (2027-2032) & (units) Table 47. Global Isothermal Nucleic Acid Amplification Sales Market Share by Region (2027-2032) Table 48. Global Isothermal Nucleic Acid Amplification Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Isothermal Nucleic Acid Amplification Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Isothermal Nucleic Acid Amplification Sales Value Share by Region (2021-2026) Table 51. Global Isothermal Nucleic Acid Amplification Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Isothermal Nucleic Acid Amplification Sales Value Share by Region (2027-2032) Table 53. Global Isothermal Nucleic Acid Amplification Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Isothermal Nucleic Acid Amplification Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Isothermal Nucleic Acid Amplification Sales by Country: 2021 VS 2025 VS 2032 (units) Table 56. Global Isothermal Nucleic Acid Amplification Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Isothermal Nucleic Acid Amplification Sales by Country (2021-2026) & (units) Table 58. Global Isothermal Nucleic Acid Amplification Sales Market Share by Country (2021-2026) Table 59. Global Isothermal Nucleic Acid Amplification Sales by Country (2027-2032) & (units) Table 60. Global Isothermal Nucleic Acid Amplification Sales Market Share by Country (2027-2032) Table 61. Global Isothermal Nucleic Acid Amplification Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Isothermal Nucleic Acid Amplification Sales Value Market Share by Country (2021-2026) Table 63. Global Isothermal Nucleic Acid Amplification Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Isothermal Nucleic Acid Amplification Sales Value Market Share by Country (2027-2032) Table 65. PreAnalytiX Company Information Table 66. PreAnalytiX Business Overview Table 67. PreAnalytiX Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. PreAnalytiX Isothermal Nucleic Acid Amplification Product Portfolio Table 69. PreAnalytiX Recent Development Table 70. Meridian Bioscience Company Information Table 71. Meridian Bioscience Business Overview Table 72. Meridian Bioscience Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Meridian Bioscience Isothermal Nucleic Acid Amplification Product Portfolio Table 74. Meridian Bioscience Recent Development Table 75. Eiken Chemical Company Information Table 76. Eiken Chemical Business Overview Table 77. Eiken Chemical Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Eiken Chemical Isothermal Nucleic Acid Amplification Product Portfolio Table 79. Eiken Chemical Recent Development Table 80. Lucigen Company Information Table 81. Lucigen Business Overview Table 82. Lucigen Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Lucigen Isothermal Nucleic Acid Amplification Product Portfolio Table 84. Lucigen Recent Development Table 85. OptiGene Company Information Table 86. OptiGene Business Overview Table 87. OptiGene Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. OptiGene Isothermal Nucleic Acid Amplification Product Portfolio Table 89. OptiGene Recent Development Table 90. NEB Company Information Table 91. NEB Business Overview Table 92. NEB Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. NEB Isothermal Nucleic Acid Amplification Product Portfolio Table 94. NEB Recent Development Table 95. Biomerieux Company Information Table 96. Biomerieux Business Overview Table 97. Biomerieux Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Biomerieux Isothermal Nucleic Acid Amplification Product Portfolio Table 99. Biomerieux Recent Development Table 100. Abbott Company Information Table 101. Abbott Business Overview Table 102. Abbott Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Abbott Isothermal Nucleic Acid Amplification Product Portfolio Table 104. Abbott Recent Development Table 105. Quidel Corporation Company Information Table 106. Quidel Corporation Business Overview Table 107. Quidel Corporation Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Quidel Corporation Isothermal Nucleic Acid Amplification Product Portfolio Table 109. Quidel Corporation Recent Development Table 110. Promega Company Information Table 111. Promega Business Overview Table 112. Promega Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Promega Isothermal Nucleic Acid Amplification Product Portfolio Table 114. Promega Recent Development Table 115. Hologic Company Information Table 116. Hologic Business Overview Table 117. Hologic Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Hologic Isothermal Nucleic Acid Amplification Product Portfolio Table 119. Hologic Recent Development Table 120. Ustar Company Information Table 121. Ustar Business Overview Table 122. Ustar Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Ustar Isothermal Nucleic Acid Amplification Product Portfolio Table 124. Ustar Recent Development Table 125. Grifols Company Information Table 126. Grifols Business Overview Table 127. Grifols Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Grifols Isothermal Nucleic Acid Amplification Product Portfolio Table 129. Grifols Recent Development Table 130. ThermoFisher Company Information Table 131. ThermoFisher Business Overview Table 132. ThermoFisher Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. ThermoFisher Isothermal Nucleic Acid Amplification Product Portfolio Table 134. ThermoFisher Recent Development Table 135. Nugen Company Information Table 136. Nugen Business Overview Table 137. Nugen Isothermal Nucleic Acid Amplification Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Nugen Isothermal Nucleic Acid Amplification Product Portfolio Table 139. Nugen Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Isothermal Nucleic Acid Amplification Distributors List Table 143. Isothermal Nucleic Acid Amplification Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Isothermal Nucleic Acid Amplification Product Image Figure 2. Global Isothermal Nucleic Acid Amplification Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 4. Global Isothermal Nucleic Acid Amplification Sales (2021-2032) & (units) Figure 5. Global Isothermal Nucleic Acid Amplification Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Isothermal Nucleic Acid Amplification Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. LAMP Image Figure 10. HDA Image Figure 11. Other Image Figure 12. Global Isothermal Nucleic Acid Amplification Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Isothermal Nucleic Acid Amplification Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Type (2021-2032) Figure 15. Global Isothermal Nucleic Acid Amplification Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Isothermal Nucleic Acid Amplification Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Isothermal Nucleic Acid Amplification Sales Value Share by Type (2021-2032) Figure 18. Research Use Image Figure 19. Foods Inspection Image Figure 20. Environment Inspection Image Figure 21. Global Isothermal Nucleic Acid Amplification Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 22. Global Isothermal Nucleic Acid Amplification Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Isothermal Nucleic Acid Amplification Sales Volume Share by Application (2021-2032) Figure 24. Global Isothermal Nucleic Acid Amplification Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Isothermal Nucleic Acid Amplification Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Isothermal Nucleic Acid Amplification Sales Value Share by Application (2021-2032) Figure 27. Global Isothermal Nucleic Acid Amplification Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 28. Global Isothermal Nucleic Acid Amplification Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Isothermal Nucleic Acid Amplification Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Isothermal Nucleic Acid Amplification Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 32. North America Isothermal Nucleic Acid Amplification Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Isothermal Nucleic Acid Amplification Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Isothermal Nucleic Acid Amplification Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 38. South America Isothermal Nucleic Acid Amplification Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Isothermal Nucleic Acid Amplification Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Isothermal Nucleic Acid Amplification Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Isothermal Nucleic Acid Amplification Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Isothermal Nucleic Acid Amplification Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • LAMP
  • HDA
  • Other
Applications
  • Research Use
  • Foods Inspection
  • Environment Inspection
Companies covered
  • PreAnalytiX
  • Meridian Bioscience
  • Eiken Chemical
  • Lucigen
  • OptiGene
  • NEB
  • Biomerieux
  • Abbott
  • Quidel Corporation
  • Promega
  • Hologic
  • Ustar
  • Grifols
  • ThermoFisher
  • Nugen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  4. 1.2.2 Global Isothermal Nucleic Acid Amplification Sales Volume (2021-2032)
  5. 1.2.3 Global Isothermal Nucleic Acid Amplification Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Isothermal Nucleic Acid Amplification Market Dynamics
  1. 2.1 Isothermal Nucleic Acid Amplification Industry Trends
  2. 2.2 Isothermal Nucleic Acid Amplification Industry Drivers
  3. 2.3 Isothermal Nucleic Acid Amplification Industry Opportunities and Challenges
  4. 2.4 Isothermal Nucleic Acid Amplification Industry Restraints
3 Isothermal Nucleic Acid Amplification Market by Company
  1. 3.1 Global Isothermal Nucleic Acid Amplification Company Revenue Ranking in 2025
  2. 3.2 Global Isothermal Nucleic Acid Amplification Revenue by Company (2021-2026)
  3. 3.3 Global Isothermal Nucleic Acid Amplification Sales Volume by Company (2021-2026)
  4. 3.4 Global Isothermal Nucleic Acid Amplification Average Price by Company (2021-2026)
  5. 3.5 Global Isothermal Nucleic Acid Amplification Company Ranking (2024-2026)
  6. 3.6 Global Isothermal Nucleic Acid Amplification Company Manufacturing Base and Headquarters
  7. 3.7 Global Isothermal Nucleic Acid Amplification Company Product Type and Application
  8. 3.8 Global Isothermal Nucleic Acid Amplification Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Isothermal Nucleic Acid Amplification Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Isothermal Nucleic Acid Amplification Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Isothermal Nucleic Acid Amplification Market by Type
  1. 4.1 Isothermal Nucleic Acid Amplification Type Introduction
  2. 4.1.1 LAMP
  3. 4.1.2 HDA
  4. 4.1.3 Other
  5. 4.2 Global Isothermal Nucleic Acid Amplification Sales Volume by Type
  6. 4.2.1 Global Isothermal Nucleic Acid Amplification Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Isothermal Nucleic Acid Amplification Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Isothermal Nucleic Acid Amplification Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Isothermal Nucleic Acid Amplification Sales Value by Type
  10. 4.3.1 Global Isothermal Nucleic Acid Amplification Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Isothermal Nucleic Acid Amplification Sales Value by Type (2021-2032)
  12. 4.3.3 Global Isothermal Nucleic Acid Amplification Sales Value Share by Type (2021-2032)
5 Isothermal Nucleic Acid Amplification Market by Application
  1. 5.1 Isothermal Nucleic Acid Amplification Application Introduction
  2. 5.1.1 Research Use
  3. 5.1.2 Foods Inspection
  4. 5.1.3 Environment Inspection
  5. 5.2 Global Isothermal Nucleic Acid Amplification Sales Volume by Application
  6. 5.2.1 Global Isothermal Nucleic Acid Amplification Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isothermal Nucleic Acid Amplification Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Isothermal Nucleic Acid Amplification Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Isothermal Nucleic Acid Amplification Sales Value by Application
  10. 5.3.1 Global Isothermal Nucleic Acid Amplification Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isothermal Nucleic Acid Amplification Sales Value by Application (2021-2032)
  12. 5.3.3 Global Isothermal Nucleic Acid Amplification Sales Value Share by Application (2021-2032)
6 Isothermal Nucleic Acid Amplification Regional Sales and Value Analysis
  1. 6.1 Global Isothermal Nucleic Acid Amplification Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isothermal Nucleic Acid Amplification Sales by Region (2021-2032)
  3. 6.2.1 Global Isothermal Nucleic Acid Amplification Sales by Region: 2021-2026
  4. 6.2.2 Global Isothermal Nucleic Acid Amplification Sales by Region (2027-2032)
  5. 6.3 Global Isothermal Nucleic Acid Amplification Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Isothermal Nucleic Acid Amplification Sales Value by Region (2021-2032)
  7. 6.4.1 Global Isothermal Nucleic Acid Amplification Sales Value by Region: 2021-2026
  8. 6.4.2 Global Isothermal Nucleic Acid Amplification Sales Value by Region (2027-2032)
  9. 6.5 Global Isothermal Nucleic Acid Amplification Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  12. 6.6.2 North America Isothermal Nucleic Acid Amplification Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  15. 6.7.2 Europe Isothermal Nucleic Acid Amplification Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  21. 6.9.2 South America Isothermal Nucleic Acid Amplification Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Sales Value Share by Country, 2025 VS 2032
7 Isothermal Nucleic Acid Amplification Country-level Sales and Value Analysis
  1. 7.1 Global Isothermal Nucleic Acid Amplification Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isothermal Nucleic Acid Amplification Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Isothermal Nucleic Acid Amplification Sales by Country (2021-2032)
  4. 7.3.1 Global Isothermal Nucleic Acid Amplification Sales by Country (2021-2026)
  5. 7.3.2 Global Isothermal Nucleic Acid Amplification Sales by Country (2027-2032)
  6. 7.4 Global Isothermal Nucleic Acid Amplification Sales Value by Country (2021-2032)
  7. 7.4.1 Global Isothermal Nucleic Acid Amplification Sales Value by Country (2021-2026)
  8. 7.4.2 Global Isothermal Nucleic Acid Amplification Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Isothermal Nucleic Acid Amplification Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Isothermal Nucleic Acid Amplification Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Isothermal Nucleic Acid Amplification Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 PreAnalytiX
  2. 8.1.1 PreAnalytiX Company Information
  3. 8.1.2 PreAnalytiX Business Overview
  4. 8.1.3 PreAnalytiX Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 PreAnalytiX Isothermal Nucleic Acid Amplification Product Portfolio
  6. 8.1.5 PreAnalytiX Recent Developments
  7. 8.2 Meridian Bioscience
  8. 8.2.1 Meridian Bioscience Company Information
  9. 8.2.2 Meridian Bioscience Business Overview
  10. 8.2.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Product Portfolio
  12. 8.2.5 Meridian Bioscience Recent Developments
  13. 8.3 Eiken Chemical
  14. 8.3.1 Eiken Chemical Company Information
  15. 8.3.2 Eiken Chemical Business Overview
  16. 8.3.3 Eiken Chemical Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eiken Chemical Isothermal Nucleic Acid Amplification Product Portfolio
  18. 8.3.5 Eiken Chemical Recent Developments
  19. 8.4 Lucigen
  20. 8.4.1 Lucigen Company Information
  21. 8.4.2 Lucigen Business Overview
  22. 8.4.3 Lucigen Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lucigen Isothermal Nucleic Acid Amplification Product Portfolio
  24. 8.4.5 Lucigen Recent Developments
  25. 8.5 OptiGene
  26. 8.5.1 OptiGene Company Information
  27. 8.5.2 OptiGene Business Overview
  28. 8.5.3 OptiGene Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 OptiGene Isothermal Nucleic Acid Amplification Product Portfolio
  30. 8.5.5 OptiGene Recent Developments
  31. 8.6 NEB
  32. 8.6.1 NEB Company Information
  33. 8.6.2 NEB Business Overview
  34. 8.6.3 NEB Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NEB Isothermal Nucleic Acid Amplification Product Portfolio
  36. 8.6.5 NEB Recent Developments
  37. 8.7 Biomerieux
  38. 8.7.1 Biomerieux Company Information
  39. 8.7.2 Biomerieux Business Overview
  40. 8.7.3 Biomerieux Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biomerieux Isothermal Nucleic Acid Amplification Product Portfolio
  42. 8.7.5 Biomerieux Recent Developments
  43. 8.8 Abbott
  44. 8.8.1 Abbott Company Information
  45. 8.8.2 Abbott Business Overview
  46. 8.8.3 Abbott Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Abbott Isothermal Nucleic Acid Amplification Product Portfolio
  48. 8.8.5 Abbott Recent Developments
  49. 8.9 Quidel Corporation
  50. 8.9.1 Quidel Corporation Company Information
  51. 8.9.2 Quidel Corporation Business Overview
  52. 8.9.3 Quidel Corporation Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Quidel Corporation Isothermal Nucleic Acid Amplification Product Portfolio
  54. 8.9.5 Quidel Corporation Recent Developments
  55. 8.10 Promega
  56. 8.10.1 Promega Company Information
  57. 8.10.2 Promega Business Overview
  58. 8.10.3 Promega Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Promega Isothermal Nucleic Acid Amplification Product Portfolio
  60. 8.10.5 Promega Recent Developments
  61. 8.11 Hologic
  62. 8.11.1 Hologic Company Information
  63. 8.11.2 Hologic Business Overview
  64. 8.11.3 Hologic Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hologic Isothermal Nucleic Acid Amplification Product Portfolio
  66. 8.11.5 Hologic Recent Developments
  67. 8.12 Ustar
  68. 8.12.1 Ustar Company Information
  69. 8.12.2 Ustar Business Overview
  70. 8.12.3 Ustar Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ustar Isothermal Nucleic Acid Amplification Product Portfolio
  72. 8.12.5 Ustar Recent Developments
  73. 8.13 Grifols
  74. 8.13.1 Grifols Company Information
  75. 8.13.2 Grifols Business Overview
  76. 8.13.3 Grifols Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Grifols Isothermal Nucleic Acid Amplification Product Portfolio
  78. 8.13.5 Grifols Recent Developments
  79. 8.14 ThermoFisher
  80. 8.14.1 ThermoFisher Company Information
  81. 8.14.2 ThermoFisher Business Overview
  82. 8.14.3 ThermoFisher Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 ThermoFisher Isothermal Nucleic Acid Amplification Product Portfolio
  84. 8.14.5 ThermoFisher Recent Developments
  85. 8.15 Nugen
  86. 8.15.1 Nugen Company Information
  87. 8.15.2 Nugen Business Overview
  88. 8.15.3 Nugen Isothermal Nucleic Acid Amplification Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Nugen Isothermal Nucleic Acid Amplification Product Portfolio
  90. 8.15.5 Nugen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isothermal Nucleic Acid Amplification Value Chain Analysis
  2. 9.1.1 Isothermal Nucleic Acid Amplification Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isothermal Nucleic Acid Amplification Sales Mode & Process
  6. 9.2 Isothermal Nucleic Acid Amplification Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isothermal Nucleic Acid Amplification Distributors
  9. 9.2.3 Isothermal Nucleic Acid Amplification Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst